AMERICAN CENTURY COMPANIES INC
Position in LYEL — Lyell Immunopharma, Inc.
CIK 748054
KANSAS CITY, MO
Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$320,378
New position
Shares Held
15,971
first reported quarter
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,388,733 across 170 Biotechnology names. LYEL ranks #127 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in LYEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $320,378 | 15,971 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||